Richard M Touma, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 220 E Frank St, Caro, MI 48723 Phone: 989-673-4106 Fax: 989-673-4502 |
John H Siegner, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 220 E Frank St, Caro, MI 48723 Phone: 989-673-4126 Fax: 989-673-4502 |
Venkataramanarasaiah Kanaparti, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 2000 Chambers Road, Caro, MI 48723 Phone: 989-673-3191 Fax: 989-673-0064 |
Dr. Yong Ja Ahadi, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2000 Chambers Road, Caro, MI 48723 Phone: 989-673-3191 Fax: 989-673-0064 |
News Archive
A new kind of knee surgery is providing much needed relief for patients in the greater Houston area. For many years, anterior cruciate ligament (ACL) reconstructions have been frequently performed to correct instability in the knee, however many patients never return to their pre-injury level of activity following surgery. That is changing, says orthopaedic surgeon Dr. William Hayes, because surgeons are now addressing injuries to the anterolateral ligament (ALL) in the knee as well.
IRIN examines the "silent epidemic" of child malnutrition in Nepal, where nearly half of all children under five have stunted growth and 13 percent of children over six months and under five years old have moderate or severe acute malnutrition, a measurement known as global acute malnutrition.
A U.S. Food and Drug Administration-funded study led by the Kaiser Permanente Northern California Division of Research found an increased risk of arterial thrombotic events (ATE) and venous thromboembolic events (VTE) - commonly referred to as blockage of arteries and blood clots, respectively - associated with drospirenone-containing birth control pills compared to four low-dose estrogen combined hormonal contraceptives.
Taconic, a leading provider of life sciences solutions, and Oncodesign(R), an innovative leader in the discovery of novel anti-cancer therapies, announce today that they have entered into an agreement to co-develop and co-promote pre-clinical oncology in vivo solutions for researchers worldwide. The agreement provides researchers with improved access to a large, diverse portfolio of translational models for use in pre-clinical oncology studies, along with supporting scientific services.
› Verified 5 days ago